Immunomodulatory Spherical Nucleic Acids*

Aleksandar F. Radovic‐Moreno,Natalia Chernyak,Christopher C. Mader,SubbaRao Nallagatla,Richard S. Kang,Liangliang Hao,David Walker,Tiffany L. Halo,Timothy J. Merkel,Clayton H. Rische,Sagar Anantatmula,Merideth Burkhart,Chad A. Mirkin,Sergei Gryaznov
DOI: https://doi.org/10.1073/pnas.1502850112
2020-01-01
Abstract:Significance We show that by organizing immunomodulatory nucleic acids into spherical nucleic acid (SNA) form, significant increases in activity are observed. Treatment of mice with cancer using immunostimulatory SNAs and nonalcoholic steatohepatitis (NASH) using immunoregulatory SNAs leads to improved disease outcomes vs. their unstructured counterparts. These improvements derive from several key SNA properties, including rapid cellular uptake, endosomal delivery, and multivalent binding. Overall, this work underscores the importance of the spatial orientation and presentation of oligonucleotides in the design of novel immunomodulators.
What problem does this paper attempt to address?